This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With Trastuzumab Deruxtecan in mBC

223 views
October 1, 2024
Comments 0
Login to view comments. Click here to Login